Reply to: Burosumab for Tumor-Induced Osteomalacia: not Enough of a Good Thing

Affiliations

• ¹ Johns Hopkins University School of Medicine, Baltimore, MD, USA.
• ² Colorado Center for Bone Research, Lakewood, CO, USA.
• ³ Duke University, Durham, NC, USA.
• ⁴ Indiana University School of Medicine, Indianapolis, IN, USA.
• ⁵ Yale University School of Medicine, New Haven, CT, USA.
• ⁶ Mayo Clinic College of Medicine, Rochester, MN, USA.
• ⁷ McGill University, Montreal, Canada.
• ⁸ Ultragenyx Pharmaceutical Inc., Novato, CA, USA.